Gabapentin
Product Images NDC 17856-0311

5 FDA label images from Atlantic Biologicals Corps · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 17856-0311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 0311)

Image Description (17856 0311)
Gabapentin oral solution 250 mg per 5 mL, packaged for delivery of 5 mL per dose. Label indicates prescription use only and storage refrigeration requirements between 2-8°C (36-46°F). Distributed by Atlantic Biologicals with manufacturing details and a barcode showing product NDC 17856-0311.*
FDA Label Image

Image Description (Image 01)

Image Description (Image 01)
Chemical structure of gabapentin showing its molecular framework including a cyclohexane ring with amino and carboxyl functional groups attached.*
FDA Label Image

Image Description (Image 02)

Image Description (Image 02)
Two line graphs depicting weekly mean pain scores over several weeks in a study population. The first graph compares placebo with gabapentin 300 mg/day, showing mean pain scores decreasing over time. The second graph compares placebo with gabapentin 1800 mg/day and 2400 mg/day doses, also showing pain score trends across weeks.*
FDA Label Image

Image Description (Image 03)

Image Description (Image 03)
A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' compares the response rates between placebo (PBO) and Gabapentin (GBP) at different dosages (3600 mg, 1800 mg, and 2400 mg) across two studies. The vertical axis shows the percentage of responders, with significant differences noted between GBP and placebo groups.*
FDA Label Image

Image Description (Image 04)

Image Description (Image 04)
A scatter plot showing difference percentages on the vertical axis and daily dose (mg) on the horizontal axis, featuring data points for three studies labeled Study a, Study b, and Study c, comparing difference percentages at daily doses ranging from 600 to 1800 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.